Company Directory - Thermo Fisher Scientific
CCI Score
CCI Score: Thermo Fisher Scientific
11.88
Latest Event
Thermo Fisher Scientific Political Contributions and Lobbying
OpenSecrets data reveals that Thermo Fisher Scientific contributed approximately $779,820 in campaign donations and spent about $1,950,000 on lobbying during the 2024 cycle, indicating active corporate political engagement.
Take Action
So what can you do? Support Thermo Fisher by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
SABOTEUR
Thermo Fisher Scientific is currently rated as a Saboteur.
Latest Events
- FEB192025
OpenSecrets data reveals that Thermo Fisher Scientific contributed approximately $779,820 in campaign donations and spent about $1,950,000 on lobbying during the 2024 cycle, indicating active corporate political engagement.
-40
Political Contributions and Lobbying Efforts
April 11
The reported figures for campaign contributions and lobbying expenses indicate significant corporate political activity. From an anti-fascist perspective, such involvement raises concerns over corporate influence on policy, which can undermine democratic accountability and potentially support authoritarian interests by prioritizing corporate benefit over public welfare.
- JAN012025
Thermo Fisher Scientific's global supply chain page emphasizes its commitment to a Supplier Code of Conduct, enforcing human rights and fair labor practices across its supply chain, while promoting supplier diversity and local economic development.
+80
Supply Chain Ethics
April 11
The article outlines Thermo Fisher Scientific's proactive approach to supply chain ethics through a robust Supplier Code of Conduct and a Supplier Diversity program. This commitment to ensuring human rights, fair labor practices, and equal opportunity among suppliers supports progressive labor and ethical sourcing practices, aligning with anti-fascist values that reject exploitation and promote diversity.
- JAN052024
On January 5, 2024, Thermo Fisher Scientific announced it would stop selling human DNA identification technology to the Chinese police in the Tibet Autonomous Region, following a similar decision in Xinjiang in 2019. Critics, however, note that the decision is limited in scope as sales to other parts of China continue.
+35
Executive Political Engagement
April 11
The announcement demonstrates executive political engagement by taking a public stand against the use of surveillance technology in regions known for human rights abuses. Although the measure is limited to Tibet (and previously Xinjiang), it marks a positive step in opposing authoritarian practices.
US Company Must Stop Supplying China’s Regime with DNA Surveillance Tech
+40
Provision of Repressive Technologies
April 11
By discontinuing sales of its human DNA identification technology to Chinese police in Tibet, Thermo Fisher is reducing the risk that its technology will be used for mass surveillance and repression. However, because the decision only covers specific regions rather than all potential abuses, there remains room for a more comprehensive ethical approach.
US Company Must Stop Supplying China’s Regime with DNA Surveillance Tech
- JAN012024
OpenSecrets provides a detailed account of Thermo Fisher Scientific's lobbying activities, outlining annual totals since 1998 and including specific lobbying on bills in 2024. This profile highlights the company's ongoing engagement in political lobbying, a practice that can prioritize corporate interests over public accountability.
-30
Political Contributions and Lobbying Efforts
April 11
The disclosed lobbying activities, tracked over time and including efforts in 2024, reflect the company's use of political influence. From an anti-fascist perspective, such corporate lobbying can undermine democratic accountability and elevate corporate interests above those of the public, contributing to a negative influence on democratic processes.
- DEC312023
Thermo Fisher Scientific published its 2023 Human Rights and Modern Slavery Transparency Statement detailing extensive measures and policies to ensure respect for human rights, elimination of modern slavery and child labor, and robust supply chain due diligence through comprehensive supplier codes, audits, training, and continuous monitoring.
+75
Labor Relations and Human Rights Practices
April 11
Thermo Fisher Scientific has established comprehensive policies to uphold labor rights and prevent modern slavery, as evidenced by its detailed Human Rights and Modern Slavery Transparency Statement. The company’s commitment to fair labor practices and adherence to multiple national and international standards is commendable.
PDF Thermo Fisher Scientific Inc. Human Rights and Modern Slavery Transparency Statement 2023
+70
Supply Chain Ethics
April 11
The statement outlines rigorous supply chain due diligence, including third-party audits, supplier risk assessments and enforceable Supplier Code of Conduct, which collectively demonstrate a strong commitment to ethical sourcing and mitigating human rights risks.
PDF Thermo Fisher Scientific Inc. Human Rights and Modern Slavery Transparency Statement 2023
- DEC312023
Thermo Fisher Scientific spent $2,080,000 on lobbying activities in 2023, as reported by OpenSecrets based on data from the Senate Office of Public Records.
-40
Political Contributions and Lobbying Efforts
April 11
The substantial lobbying expenditure of $2,080,000 in 2023 indicates an active engagement in influencing political processes. Such political spending can be associated with efforts that ultimately reinforce existing power structures and may indirectly support authoritarian policies, making it a negative action from an anti-fascist perspective.
- DEC312023
Thermo Fisher Scientific released its Modern Slavery Statement for the financial year ending 2023. The statement outlines enhanced ethical supply chain measures including robust supplier due diligence, third-party screening, and mandatory staff ethics training aimed at preventing modern slavery and human trafficking.
+60
Labor Relations and Human Rights Practices
April 11
The statement demonstrates a strong commitment to protecting human rights through comprehensive measures such as enforcing a Supplier Code of Conduct, conducting due diligence, and implementing staff training. These measures help prevent exploitative labor practices and modern slavery, reflecting positive labor relations and human rights practices.
+60
Supply Chain Ethics
April 11
The detailed outline of supplier due diligence, centralized procurement practices, third party screening platforms, and contractual requirements for suppliers underscores the company’s commitment to ethical supply chain practices. These initiatives ensure that suppliers adhere to standards that minimize risks of modern slavery and human trafficking.
- NOV012023
Thermo Fisher Scientific's PAC donated a total of $225,359 to federal candidates during the 2023-2024 election cycle, with contributions spread across both Democratic and Republican candidates. Such political contributions illustrate a corporate engagement in the political process.
-20
Political Contributions and Lobbying Efforts
April 11
The reported PAC contributions, totaling $225,359, were allocated to a mix of candidates from both major parties, including some Republicans with tendencies towards authoritarian policies. This level of political spending by Thermo Fisher Scientific reflects a willingness to engage in political processes that may undermine anti-fascist values by potentially supporting authoritarian-leaning candidates.
Thermo Fisher Scientific PAC Contributions to Federal Candidates
- JUN012023
Thermo Fisher Scientific has ceased the sale of its DNA identification kits in Tibet following months of complaints from rights groups and investors over potential human rights abuses, including the misuse of technology for mass surveillance similar to that in Xinjiang.
+80
Technology and Services Impact
April 11
By halting sales of DNA identification kits in Tibet, Thermo Fisher reduces the risk of its technology being used for repressive surveillance that could enable human rights abuses under an authoritarian regime, representing a progressive step in curbing corporate complicity in state repression.
Thermo Fisher ceases DNA kit sales in Tibet over human rights concerns
+70
Business Practices and Ethical Responsibility
April 11
The decision reflects a responsible business practice by addressing ethical concerns and responding to pressure from investors and human rights advocates, thereby upholding ethical standards in its operational practices.
Thermo Fisher ceases DNA kit sales in Tibet over human rights concerns
- JUN012023
Thermo Fisher Scientific announced in mid-2023 that it would cease sales of its DNA testing products in Tibet amid growing concerns over potential use of its technology for mass surveillance and human rights abuses. This decision, following similar actions in Xinjiang, comes in response to bipartisan pressure from U.S. lawmakers.
+40
Public and Political Behavior
April 11
The decision reflects a proactive response to political pressure and criticism regarding complicity in authoritarian surveillance practices. By halting sales in a sensitive region, Thermo Fisher is distancing itself from potential human rights abuses, marking a positive public and political action.
US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China
+30
Business Practices and Ethical Responsibility
April 11
By discontinuing sales of its human identification products in Tibet, Thermo Fisher demonstrates an ethical business practice by mitigating its risk of being complicit in human rights violations. This move aligns with broader expectations of corporate ethical responsibility.
US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China
+30
Technology and Services Impact
April 11
The halt in sales prevents the potential misuse of Thermo Fisher’s technology for mass surveillance in a politically sensitive region. This action reduces the risk that its products will fuel repressive practices, thereby positively impacting the technology and services domain.
US biotech company halts sales of DNA kits in Tibet, as lawmakers mull more export controls on China
- DEC152022
Bipartisan commissioners from the Congressional-Executive Commission on China have sent a letter to Thermo Fisher Scientific's CEO questioning the company’s sale and servicing of DNA sequencers and replacement parts used by police in the Tibet Autonomous Region. The inquiry raises concerns that the products could facilitate mass DNA collection and state surveillance, potentially contributing to human rights abuses, echoing past controversies in Xinjiang.
-70
Supply Chain Ethics
April 11
The inquiry targets Thermo Fisher's supply chain practices by questioning how its products ended up in the hands of authorities in Tibet, which could be used for mass DNA collection and surveillance. This raises serious concerns about the company’s oversight and ethical responsibility in its supply chain, potentially facilitating human rights abuses.
Commissioners Ask Thermo Fisher if Products Involved in Human Rights Abuses in Tibet
-65
Provision of Repressive Technologies
April 11
The letter highlights the potential use of Thermo Fisher's DNA sequencers in mass surveillance operations linked to human rights abuses in Tibet, suggesting that the technology provided may be serving repressive state functions. This represent a troubling use of technology that could aid authoritarian surveillance efforts.
Commissioners Ask Thermo Fisher if Products Involved in Human Rights Abuses in Tibet
- JAN012022
The OpenSecrets PAC profile reveals that Thermo Fisher Scientific raised $222,111 in political contributions during the 2021-2022 election cycle, and highlights the involvement of lobbyists with former governmental staff. While the amount is modest, such political contributions raise concerns about corporate influence in political processes.
-10
Political Contributions and Lobbying Efforts
April 11
Thermo Fisher Scientific's recorded PAC contributions, although relatively modest at $222,111, indicate participation in the political funding arena. In an anti-fascist perspective, any corporate involvement in political contributions can risk undue influence on democratic processes. Here, while no direct link to far-right or authoritarian candidates is evident, the involvement in political funding raises concerns about potential indirect support to broader authoritarian influences through lobbying activities.
- FEB222019
Thermo Fisher Scientific announced that it would stop selling human identification technology in China's Xinjiang region following mounting criticism from human rights groups and a high-profile exposé. The move, though seen as necessary in light of abuses in Xinjiang, leaves open questions about its other sales channels and overall approach to technology ethics in China.
+20
Business Practices and Ethical Responsibility
April 11
The decision reflects an internal reassessment of ethical business practices amid human rights concerns, marking a positive shift in corporate ethics. However, the limited scope of the action—focusing only on the Xinjiang region—means that broader issues in other sales channels remain unaddressed.
+40
Technology and Services Impact
April 11
By ceasing sales of technology that can be used for mass surveillance and human rights abuses, Thermo Fisher takes a notable step towards reducing the risk of supporting authoritarian practices. This action contributes positively to the responsible use of technology, although its limited geographic scope raises concerns regarding the overall commitment to human rights.
Alternatives

Corporation
45.62

Corporation
0.00

Corporation
0.00

Corporation
-20.00

Thousand Oaks, USA
13.63

Foster City, USA
1.64

Abbott Park, United States
-41.78

Houston, United States
13.52
Kenilworth, United States
12.75
Somerset, United States
1.18
Corporate Financials
- Revenue
- 2025
- $29.50B
- Total Assets
- 2025
- $66.00B
- Operating Income
- 2025
- $5.00B
- Total Equity
- 2025
- $25.00B
Employees: 100,000
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 423450
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)
- 621511
- Medical Laboratories